Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification

PURPOSE: MET exon 14 skipping is one of the rare mutations in non-small cell lung cancer (NSCLC), involving its pathogenesis and progression. The performances of several MET inhibitors in clinical trials have been validated based on NGS, immunohistochemistry (IHC), and gene copy number assessments....

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Caixia, Qiu, Yanyi, Zhang, Juan, Wei, Wei, Gao, Hongbian, Yuan, Yong, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318750/
https://www.ncbi.nlm.nih.gov/pubmed/37400762
http://dx.doi.org/10.1186/s12890-023-02482-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318750/
https://www.ncbi.nlm.nih.gov/pubmed/37400762
http://dx.doi.org/10.1186/s12890-023-02482-9

Ejemplares similares